We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

31 hedge funds and large institutions have $24M invested in Apollo Endosurgery, Inc. in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

7% more funds holding

Funds holding: 2931 (+2)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

11% less capital invested

Capital invested by funds: $26.9M → $24M (-$2.91M)

38% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 8

Holders
31
Holders Change
+2
Holders Change %
+6.9%
% of All Funds
0.61%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
6
Increased
5
Reduced
8
Closed
4
Calls
Puts
Net Calls
Net Calls Change

APEN Hedge Fund Activity: Q4 2019 in Review

31 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q4 2019, worth a combined $24M — down 11% from $26.9M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new APEN positions and 4 closed out — a net gain of 2 holders — while 5 added to existing stakes and 8 trimmed.

The largest buyer was Stonepine Capital Management, adding an estimated $545K. The largest seller was Russell Investments Group, cutting an estimated $543K.

  • 31 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q4 2019, up from 29 in Q3 2019.
  • Funds reported $24M of Apollo Endosurgery, Inc. stock for Q4 2019, down 11% quarter-over-quarter.
  • 6 funds opened new Apollo Endosurgery, Inc. positions in Q4 2019 and 4 closed out, a net change of +2 holders.
  • The largest Apollo Endosurgery, Inc. buyer in Q4 2019 was Stonepine Capital Management, an estimated $545K added.
  • The largest Apollo Endosurgery, Inc. seller in Q4 2019 was Russell Investments Group, an estimated $543K sold.

Based on aggregated 13F filings for Q4 2019.